232 related articles for article (PubMed ID: 23667456)
1. Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.
Zhang S; Fujita H; Mitsui H; Yanofsky VR; Fuentes-Duculan J; Pettersen JS; Suárez-Fariñas M; Gonzalez J; Wang CQ; Krueger JG; Felsen D; Carucci JA
PLoS One; 2013; 8(5):e62154. PubMed ID: 23667456
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
[TBL] [Abstract][Full Text] [Related]
3. Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage.
Freeman A; Bridge JA; Maruthayanar P; Overgaard NH; Jung JW; Simpson F; Prow TW; Soyer HP; Frazer IH; Freeman M; Wells JW
PLoS One; 2014; 9(10):e110928. PubMed ID: 25340823
[TBL] [Abstract][Full Text] [Related]
4. Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio.
Azzimonti B; Zavattaro E; Provasi M; Vidali M; Conca A; Catalano E; Rimondini L; Colombo E; Valente G
Br J Dermatol; 2015 Jan; 172(1):64-73. PubMed ID: 24910265
[TBL] [Abstract][Full Text] [Related]
5. Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma.
Abikhair Burgo M; Roudiani N; Chen J; Santana AL; Doudican N; Proby C; Felsen D; Carucci JA
JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185657
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-γ, IL-2 and IL-2R.
Zhao J; Zhao J; Perlman S
PLoS One; 2012; 7(9):e46241. PubMed ID: 23029447
[TBL] [Abstract][Full Text] [Related]
7. Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients.
Strobel SB; Safferling K; Lahrmann B; Hoffmann JH; Enk AH; Hadaschik EN; Grabe N; Lonsdorf AS
Br J Dermatol; 2018 Aug; 179(2):405-412. PubMed ID: 29479687
[TBL] [Abstract][Full Text] [Related]
8. Intracellular CTLA4 and regulatory T cells in patients with laryngeal squamous cell carcinoma.
Erfani N; Khademi B; Haghshenas MR; Mojtahedi Z; Khademi B; Ghaderi A
Immunol Invest; 2013; 42(2):81-90. PubMed ID: 23252863
[TBL] [Abstract][Full Text] [Related]
9. Orthotopic tongue squamous cell carcinoma (SCC) model exhibiting a different tumor-infiltrating T-cell status with margin-restricted CD8
Kashima Y; Nishii N; Tachinami H; Furusawa E; Nagai S; Harada H; Azuma M
Biochem Biophys Res Commun; 2020 May; 526(1):218-224. PubMed ID: 32204917
[TBL] [Abstract][Full Text] [Related]
10. Immune phenotype of peripheral blood cells and skin squamous cell carcinoma in organ transplant recipients.
Dziunycz P; Hofbauer GF
Expert Rev Clin Immunol; 2010 May; 6(3):359-62. PubMed ID: 20441422
[TBL] [Abstract][Full Text] [Related]
11. Recovery Profiles of T-Cell Subsets Following Low-Dose Total Body Irradiation and Improvement With Cinnamon.
Zheng X; Guo Y; Wang L; Zhang H; Wang S; Wang L; An L; Zhou X; Li X; Yao C
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1118-26. PubMed ID: 26475064
[TBL] [Abstract][Full Text] [Related]
12. Effector Antitumor and Regulatory T Cell Responses Influence the Development of Nonmelanoma Skin Cancer in Kidney Transplant Patients.
Crespo E; Fernandez L; Lúcia M; Melilli E; Lauzurica R; Penin RM; Quer A; Luque S; Quero M; Manonelles A; Torras J; Cruzado JM; Cañas L; Grinyó JM; Bestard O
Transplantation; 2017 Sep; 101(9):2102-2110. PubMed ID: 28403126
[TBL] [Abstract][Full Text] [Related]
13. Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells.
Khan S; Burt DJ; Ralph C; Thistlethwaite FC; Hawkins RE; Elkord E
Clin Immunol; 2011 Jan; 138(1):85-96. PubMed ID: 21056008
[TBL] [Abstract][Full Text] [Related]
14. Comparison of immunosuppressive and immunomodulatory cells in keratoacanthoma and cutaneous squamous cell carcinoma.
Kambayashi Y; Fujimura T; Aiba S
Acta Derm Venereol; 2013 Nov; 93(6):663-8. PubMed ID: 23572151
[TBL] [Abstract][Full Text] [Related]
15. [Altered Treg and IL-1A Expression in the Immune Microenvironment
of Lung Squamous-cell Cancer after EGFR Blockade].
He H; Qi L; Hou Y
Zhongguo Fei Ai Za Zhi; 2017 Mar; 20(3):143-148. PubMed ID: 28302215
[TBL] [Abstract][Full Text] [Related]
16. Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate.
Mühleisen B; Petrov I; Gächter T; Kurrer M; Schärer L; Dummer R; French LE; Hofbauer GF
Histopathology; 2009 Jul; 55(1):67-76. PubMed ID: 19614769
[TBL] [Abstract][Full Text] [Related]
17. CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells.
Zhou X; Su YX; Lao XM; Liang YJ; Liao GQ
Oral Oncol; 2016 Feb; 53():27-35. PubMed ID: 26631955
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 Expression, T-lymphocyte Subpopulations and Langerhans Cells in Cutaneous Squamous Cell Carcinoma and Precursor Lesions.
Stravodimou A; Tzelepi V; Balasis S; Georgiou S; Papadaki H; Mouzaki A; Melachrinou M; Kourea EP
Anticancer Res; 2021 Jul; 41(7):3439-3448. PubMed ID: 34230139
[TBL] [Abstract][Full Text] [Related]
19. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood.
Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J
Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259
[TBL] [Abstract][Full Text] [Related]
20. Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.
Fattorossi A; Battaglia A; Buzzonetti A; Minicuci G; Riso R; Peri L; Scambia G; Evoli A
J Clin Immunol; 2008 Mar; 28(2):194-206. PubMed ID: 18000743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
